Edwards Lifesciences CorporationEWNYSE
Loading
Price to Sales HistoryFair Value
Percentile Rank57
3Y CAGR-1.4%
5Y CAGR-8.7%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-1.4%/yr
vs -0.1%/yr prior
5Y CAGR
-8.7%/yr
Recent acceleration
Acceleration
-1.4pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 8.22 | +1.0% |
| 2024 | 8.13 | -11.9% |
| 2023 | 9.23 | +7.6% |
| 2022 | 8.58 | -44.4% |
| 2021 | 15.43 | +19.2% |
| 2020 | 12.95 | +15.9% |
| 2019 | 11.18 | +29.8% |
| 2018 | 8.61 | +24.4% |
| 2017 | 6.92 | +2.8% |
| 2016 | 6.73 | - |